BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 16931572)

  • 1. Caveolin-1 regulates cellular trafficking and function of the glucagon-like Peptide 1 receptor.
    Syme CA; Zhang L; Bisello A
    Mol Endocrinol; 2006 Dec; 20(12):3400-11. PubMed ID: 16931572
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lipid raft-dependent glucagon-like peptide-2 receptor trafficking occurs independently of agonist-induced desensitization.
    Estall JL; Yusta B; Drucker DJ
    Mol Biol Cell; 2004 Aug; 15(8):3673-87. PubMed ID: 15169869
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Agonist-induced internalisation of the glucagon-like peptide-1 receptor is mediated by the Gαq pathway.
    Thompson A; Kanamarlapudi V
    Biochem Pharmacol; 2015 Jan; 93(1):72-84. PubMed ID: 25449603
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidence for a role of caveolin-1 in neurokinin-1 receptor plasma-membrane localization, efficient signaling, and interaction with beta-arrestin 2.
    Kubale V; Abramović Z; Pogacnik A; Heding A; Sentjurc M; Vrecl M
    Cell Tissue Res; 2007 Nov; 330(2):231-45. PubMed ID: 17713785
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functional consequences of glucagon-like peptide-1 receptor cross-talk and trafficking.
    Roed SN; Nøhr AC; Wismann P; Iversen H; Bräuner-Osborne H; Knudsen SM; Waldhoer M
    J Biol Chem; 2015 Jan; 290(2):1233-43. PubMed ID: 25451942
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Real-time trafficking and signaling of the glucagon-like peptide-1 receptor.
    Roed SN; Wismann P; Underwood CR; Kulahin N; Iversen H; Cappelen KA; Schäffer L; Lehtonen J; Hecksher-Soerensen J; Secher A; Mathiesen JM; Bräuner-Osborne H; Whistler JL; Knudsen SM; Waldhoer M
    Mol Cell Endocrinol; 2014 Feb; 382(2):938-49. PubMed ID: 24275181
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Localization of the kappa opioid receptor in lipid rafts.
    Xu W; Yoon SI; Huang P; Wang Y; Chen C; Chong PL; Liu-Chen LY
    J Pharmacol Exp Ther; 2006 Jun; 317(3):1295-306. PubMed ID: 16505160
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glucagon-like peptide-1 receptor activation inhibits growth and augments apoptosis in murine CT26 colon cancer cells.
    Koehler JA; Kain T; Drucker DJ
    Endocrinology; 2011 Sep; 152(9):3362-72. PubMed ID: 21771884
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Second extracellular loop of human glucagon-like peptide-1 receptor (GLP-1R) has a critical role in GLP-1 peptide binding and receptor activation.
    Koole C; Wootten D; Simms J; Miller LJ; Christopoulos A; Sexton PM
    J Biol Chem; 2012 Feb; 287(6):3642-58. PubMed ID: 22147710
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential impact of amino acid substitutions on critical residues of the human glucagon-like peptide-1 receptor involved in peptide activity and small-molecule allostery.
    Koole C; Wootten D; Simms J; Miller LJ; Christopoulos A; Sexton PM
    J Pharmacol Exp Ther; 2015 Apr; 353(1):52-63. PubMed ID: 25630467
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Second extracellular loop of human glucagon-like peptide-1 receptor (GLP-1R) differentially regulates orthosteric but not allosteric agonist binding and function.
    Koole C; Wootten D; Simms J; Savage EE; Miller LJ; Christopoulos A; Sexton PM
    J Biol Chem; 2012 Feb; 287(6):3659-73. PubMed ID: 22147709
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The putative signal peptide of glucagon-like peptide-1 receptor is not required for receptor synthesis but promotes receptor expression.
    Ge Y; Yang D; Dai A; Zhou C; Zhu Y; Wang MW
    Biosci Rep; 2014 Nov; 34(6):e00152. PubMed ID: 25330813
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Constructing glucagon like peptide-1 receptor fused with derivatives of GFP for visualizing protein-protein interaction in living cells.
    Bavec A
    Mol Biol Rep; 2010 Jul; 37(6):2749-55. PubMed ID: 19757164
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of D1 dopamine receptor trafficking and signaling by caveolin-1.
    Kong MM; Hasbi A; Mattocks M; Fan T; O'Dowd BF; George SR
    Mol Pharmacol; 2007 Nov; 72(5):1157-70. PubMed ID: 17699686
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A human glucagon-like peptide-1 receptor polymorphism results in reduced agonist responsiveness.
    Beinborn M; Worrall CI; McBride EW; Kopin AS
    Regul Pept; 2005 Aug; 130(1-2):1-6. PubMed ID: 15975668
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of a cysteine-deprived and C-terminally truncated GLP-1 receptor.
    Underwood CR; Knudsen LB; Garibay PW; Peters GH; Reedtz-Runge S
    Peptides; 2013 Nov; 49():100-8. PubMed ID: 24045233
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glucagon-like peptide 1 receptor expression in primary porcine proximal tubular cells.
    Schlatter P; Beglinger C; Drewe J; Gutmann H
    Regul Pept; 2007 Jun; 141(1-3):120-8. PubMed ID: 17276524
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Central glucagon-like peptide 1 receptor-induced anorexia requires glucose metabolism-mediated suppression of AMPK and is impaired by central fructose.
    Burmeister MA; Ayala J; Drucker DJ; Ayala JE
    Am J Physiol Endocrinol Metab; 2013 Apr; 304(7):E677-85. PubMed ID: 23341495
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of glucagon-like peptide-1 receptor and calcium-sensing receptor signaling by L-histidine.
    Leech CA; Habener JF
    Endocrinology; 2003 Nov; 144(11):4851-8. PubMed ID: 12959987
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activation of glucagon-like peptide-1 receptor inhibits growth and promotes apoptosis of human pancreatic cancer cells in a cAMP-dependent manner.
    Zhao H; Wei R; Wang L; Tian Q; Tao M; Ke J; Liu Y; Hou W; Zhang L; Yang J; Hong T
    Am J Physiol Endocrinol Metab; 2014 Jun; 306(12):E1431-41. PubMed ID: 24801389
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.